Transparency Market Research
Single User License: Myocardial Ischemia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
USD 4315.5
Flat 10% Discount!! Free Customization as per your requirement You will get Custom Report at Syndicated Report price Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Myocardial Ischemia Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Myocardial ischemia is characterized by a specific condition, where there is an insufficient flow of blood to the heart muscle (myocardium) through coronary arteries. Due to an obstruction or constriction of the arteries, the heart is not able to pump oxygenated blood and other vital nutrients to the body efficiently and finally leads to destruction of the heart muscles. Blockage of an artery (due to atherosclerotic plaque), blood clots, heart muscle diseases and artery spasms or contraction are few of the causes of myocardial ischemia. Various symptoms of myocardial ischemia include breathlessness, dizziness, heart palpitations, weakness, shoulder pain and chest pain (angina pectoris). Browse Full Report with TOC: http://www.transparencymarketresearch.com/myocardial-ischemia-market.html Based on diagnosis, the myocardial ischemia market can be segmented as follows: •
Cardiac CT scan: Coronary artery clarification can be determined by CT scans and can aid in the diagnosis of coronary atherosclerotic
•
Electrocardiogram (ECG) : ECG reveals a heart’s activity with the help of electrodes attached to the patient’s chests, arms and legs
•
Nuclear scan: Certain radioactive materials are injected into a patient’s bloodstream and are detected by special cameras as they flow through the blood. Dark spots appear on the scan in those regions where there is limited bloodflow
•
Coronary angiography: Coronary angiography uses X-ray imaging to examine to the heart’s internal blood vessels
•
Holter monitoring: Holter monitor is a small, portable device which is worn by a patient to record heart rhythm
Based on treatment, the myocardial ischemia can be segmented as follows: Medications: •
Angiotensin-converting enzyme (ACE) inhibitors: These inhibitors prevent an enzyme to produce angiotensin II, a substance which affects the cardiovascular system
•
Aspirin: Aspirin can reduce the ability of blood clotting, and hence can prevent constriction of coronary arteries
•
Beta blockers: Beta blockers control the pace of a patient’s heartbeat, and relaxes the heart muscles
•
Nitroglycerine: It improves the blood flow within the body by repairing the arterial blood vessels
Surgery methods: •
Angioplasty, also referred to as percutaneous coronary intervention (PCI)
•
Coronary artery bypass surgery
Based on geography, the myocardial ischemia market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World. Out of these four regions, North America dominates the myocardial ischemia market followed by Europe. The major driving factors for the growth of myocardial ischemia market are increase in the prevalence of various heart-related diseases, and growing awareness of the population about cardiovascular diseases coupled with geriatric population which is rapidly increasing. According to a survey, approximately 1.5 million cases of myocardial ischemia occur annually in the United States. Moreover, technological advancements and increasing competition from small market players have further fueled the growth of myocardial ischemia market. Asia Pacific is developing rapidly and is considered to be as one of the most promising markets for the augmentation of myocardial ischemia market. The factors which will contribute towards the growth of this market in Asia Pacific are presence of emerging economies, constantly changing lifestyles of people which have accelerated the prevalence of serious heart ailments, and
better healthcare infrastructures. Furthermore, the increasing need of individuals to opt for the best technology available for their treatment would most probably accentuate the growth of myocardial ischemia market in various Asian countries. Various pharmaceutical companies are constantly trying to come up with novel therapeutic developments for the treatment of myocardial ischemia. Some of the top major players operating in myocardial ischemia therapeutics market are Baxter International, Inc., Boston Scientific Corporation, Cardium Therapeutics, Inc., ViroMed Co. Ltd., Atrium Medical Corporation, Vasade Biosciences, Inc. and many others. Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports1.html This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2959 About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Followed LinkedIn :- https://www.linkedin.com/today/post/article/20140819053737-349336221-myocardial-ischemia-market-20142020 Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY —12207 United States Tel: +1-518-618-1030 USA —Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com/ Website: http://www.transparencymarketresearch.com/
Browse Market Research Blogs: http://researchreportsindustry.wordpress.com/ http://marketingfirmblog.wordpress.com/